Completely Resected Stage Iib C Melanoma clinical trials

Explore recruiting completely resected stage iib c melanoma clinical trials.

Also recruiting in Europe

Completely Resected Stage Iib C Melanoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double-Blind Study of Adjuvant Immunotherapy with Nivolumab versus Placebo after Complete Resection of Stage IIB/C Melanoma (CheckMate 76K: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 76K)

Belgium, Czechia, Germany, Italy, Netherlands, Finland +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Completely Resected Stage Iib C Melanoma trials by city

Completely Resected Stage Iib C Melanoma in Toronto Completely Resected Stage Iib C Melanoma in Vancouver Completely Resected Stage Iib C Melanoma in Montreal Completely Resected Stage Iib C Melanoma in Calgary Completely Resected Stage Iib C Melanoma in Edmonton Completely Resected Stage Iib C Melanoma in Ottawa Completely Resected Stage Iib C Melanoma in Winnipeg Completely Resected Stage Iib C Melanoma in Quebec City Completely Resected Stage Iib C Melanoma in Hamilton Completely Resected Stage Iib C Melanoma in Kitchener Completely Resected Stage Iib C Melanoma in London Completely Resected Stage Iib C Melanoma in Halifax Completely Resected Stage Iib C Melanoma in New York Completely Resected Stage Iib C Melanoma in Los Angeles Completely Resected Stage Iib C Melanoma in Chicago Completely Resected Stage Iib C Melanoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease